Volume spike POLYMED.BO Poly Medicure BSE pre-market Jan 2026: Watch INR 1,900
POLYMED.BO stock shows a clear pre-market volume spike on BSE ahead of earnings. Volume is 11,610.00 versus an average of 9,756.00, signaling elevated trade interest. The current price is INR 1,668.25 and intraday range is INR 1,651.45–1,714.20. Traders should watch order flow and nearby resistance at INR 1,900.00 for short-term bias.
POLYMED.BO stock: Pre-market volume spike and price action
The main market signal is a volume uptick in pre-market hours on BSE. Volume of 11,610.00 compares with average volume 9,756.00, giving a relative volume of about 1.19x, which qualifies as a volume spike for this name. Price opened at INR 1,702.55 then settled to INR 1,668.25, with the session high at INR 1,714.20.
Volume, liquidity and what the spike means
A 1.19x volume increase suggests fresh participation, not just routine noise. Higher pre-market volume often precedes directional moves when paired with catalyst or positioning ahead of earnings. Poly Medicure’s shares outstanding are 101,359,490.00, so traders should still expect limited block liquidity versus larger-cap healthcare peers.
Valuation and fundamentals for POLYMED.BO stock
Poly Medicure (POLYMED.BO) trades at a trailing PE of 46.08 with EPS of 35.70 and PB of 5.71, indicating premium valuation versus the Healthcare sector average PE 39.94. The company shows a healthy current ratio 3.89 and low debt to equity 0.08, with net profit margin 21.14%. These fundamentals support medium-term growth claims but leave limited margin for upside without revenue expansion.
Technicals and trade set-up for short-term traders
Short-term indicators are mixed but usable for a volume-spike trade. RSI is 45.55, MACD histogram is 5.85, and Bollinger middle band sits at INR 1,789.96. Key technical levels: support INR 1,650.00, immediate resistance INR 1,900.00, and a bullish breakout above INR 1,900.00 could open a run to the 50-day average INR 1,855.80 and then the 200-day average INR 2,070.72.
Meyka AI rates POLYMED.BO with a score out of 100 and forecast
Meyka AI rates POLYMED.BO with a score out of 100: 65.28 (Grade B, suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of INR 2,578.64, versus the current INR 1,668.25, implying an upside of 54.59%. Forecasts are model-based projections and not guarantees. Meyka AI is an AI-powered market analysis platform.
Risks, catalysts and upcoming events
Primary near-term catalyst is the earnings call on 29 Jan 2026, which could widen intraday moves. Risks include stretched valuation metrics, inventory cycle (days inventory 225.48), and mixed interest coverage -0.34, which indicate occasional earnings volatility. Monitor sector trends in Healthcare, where peers show average volatility; a negative sector swing could pressure POLYMED.BO.
Final Thoughts
POLYMED.BO stock is seeing a measurable pre-market volume spike on BSE, with volume 11,610.00 and relative volume about 1.19x. The spike suggests traders are positioning ahead of the 29 Jan 2026 earnings call. Fundamentals show solid margins, low leverage, and a PE of 46.08, so upside requires growth or positive guidance. For short-term traders, a breakout above INR 1,900.00 would be a bullish trigger; failure to hold INR 1,650.00 would favor sellers. Meyka AI’s forecast model projects INR 2,578.64 over a year, implying +54.59% from the current INR 1,668.25. Forecasts are model-based projections and not guarantees. Use size limits and stop-losses given the company’s premium valuation and limited intraday liquidity. Sources: Poly Medicure website and Company data image.
FAQs
What caused the POLYMED.BO stock volume spike pre-market?
The spike reflects higher trade interest ahead of Poly Medicure’s earnings on 29 Jan 2026. Volume rose to 11,610.00 from an average 9,756.00, a 1.19x increase, suggesting positioning and order flow, not necessarily news.
Is POLYMED.BO stock cheap or expensive now?
Valuation is premium: trailing PE 46.08 and PB 5.71. Strong margins and low debt support the price, but the stock needs growth or positive guidance to justify current multiples.
What price targets should traders watch for POLYMED.BO stock?
Near-term resistance is INR 1,900.00. A breakout could target the 50-day INR 1,855.80 then 200-day INR 2,070.72. Meyka AI’s year forecast is INR 2,578.64.
How should I trade the pre-market volume spike in POLYMED.BO stock?
Watch order flow and trade small positions. Use stops below INR 1,650.00 and consider profit targets near INR 1,900.00. Earnings on 29 Jan 2026 increase event risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
